Good piece on how Lilly plans to put money to work on the M&A front in 2020.

Will Dermira be the first of many buyouts across the biotech industry in 2020. Article discusses

The 5 most watched FDA approval dates in the first quarter

Quick list of the important events on the Biotech calendar early in 2020

Benzinga with quick list of 10 potential buyout targets in biotech in 2020

Good piece on the happenings in the sickle cell disease space after the big ASH conference

Comprehensive piece of the primary NASH programs investors need to keep an eye in the quarters and years ahead.

$BOLD becomes the second big acquisition in the biotech space this morning in 8 days (MDCO last week). Who's next? …

Big week for biotech as far as conferences and some trial presentations. Good piece on what to watch for this week.

Quick piece on three key FDA decisions still left in 2019